Medical Conditions - Hereditary Transthyretin Mediated Amyloidosis

Patisiran is a pharmacological choice to tackle hereditary transthyretin-mediated amyloidosis. Continue reading to know more.

Inotersen treats polyneuropathy of hereditary transthyretin-mediated amyloidosis by reducing abnormal protein production and slowing disease progression.